Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Companion Diagnostics market 2020 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026

  • Purchase Options

 
Report Description
Companion diagnostic (CDx) is a diagnostic tool used to determine the suitability of a drug therapy to the patient. It has become a critical part of targeted cancer therapy that allows for development of personalized therapy can be developed and administered to the patient. Whole blood samples, tissues samples, or buccal samples are collected and tested for diagnosis and identification of targeted disease biomarker. CDx is usually utilized in identifying genetic mutations and the health and treatment approach implications. In July 2016, the U.S. FDA released a draft guideline for development of a therapeutic product accompanying an IVD companion diagnostic. Companion diagnostics include Gleevec (imatinib mesylate) and BCR-ABL LDT and DAKO C-KIT PharmDx, Herceptin (trastuzumab) and DAKO Herceptest; and Nolvaldex (tamoxifen) and laboratory-developed estrogen receptor positive test.
Market Dynamics
Companion diagnostics are beneficial for pharmaceutical companies who face challenges with respect to high drug development cost, safety and outcome of clinical trials, and long product approval time. Companion diagnostics lowers development costs, improves time to market and enhances drug safety by enabling rapid identification of target biomarker and the most effective drug therapy. For patients, the technology provides better treatment outcomes and lower morbidity risk. Use of technologies such as PCR, immunohistochemistry, and gene sequencing has enabled accurate diagnosis and determination of targeted cancer therapy. As the CDx tests also aid in revealing the off-target effects of a drug along with identification of a molecular target, CDx have become and indispensable tool for oncologists.
Market Taxonomy
This report segments the global companion diagnostics market on the basis of application, technology, and geography. On the basis of application, the market is categorized into breast cancer, lung cancer, colorectal cancer, gastric cancer, melanoma, and others. On the basis of technology, the market is segmented into immunohistochemistry, real-time PCR, gene sequencing, Fluorescence in situ hybridization (FISH), and others. For comprehensive understanding of market dynamics, the global companion diagnostics market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
Key features of the study:
• This report provides in-depth analysis of the companion diagnostics and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 - 2024, considering 2015 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global companion diagnostics market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
• Key companies covered as a part of this study include Abbott Laboratories, Inc., Agilent Technologies, Inc., Danaher Corporation, GE Healthcare, Qiagen N.V., Roche Diagnostics, Myriad Genetics, Inc., bioMérieux SA, Illumina, Inc. and Siemens Healthcare
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, technology upgrades, market expansion, and marketing tactics
• The global companion diagnostics market report caters to various stakeholders in this industry, including investors, device manufacturers, distributors and suppliers for companion diagnostics, research and consulting firms, new entrants, and financial analysts
• Various strategy matrices used in analyzing the companion diagnostics market would provide stakeholders vital inputs to make strategic decisions accordingly
Detailed Segmentation:
• Global Companion Diagnostics Market, By Application:
o Breast Cancer
o Lung Cancer
o Colorectal Cancer
o Gastric Cancer
o Melanoma
o Others
• Global Companion Diagnostics Market, By Technology:
o Immunohistochemistry
o Real-time PCR
o Gene Sequencing
o FISH
o Others
• Global Companion Diagnostics Market, By Geography:
o North America
 U.S.
 U.S. Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 U.S. Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
 Canada
 Canada Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 Canada Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
o Europe
 U.K.
 U.K. Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 U.K. Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
 Germany
 Germany Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 Germany Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
 Italy
 Italy Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 Italy Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
 France
 France Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 France Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
 Spain
 Spain Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 Spain Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
 Russia
 Russia Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 Russia Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
 Rest of Europe
 Rest of Europe Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 Rest of Europe Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
o Asia-Pacific
 China
 China Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 China Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
 India
 India Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 India Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
 Japan
 Japan Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 Japan Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
 ASEAN
 ASEAN Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 ASEAN Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
 Australia
 Australia Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 Australia Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
 South Korea
 South Korea Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 South Korea Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
 Rest of Asia Pacific (APAC)
 Rest of Asia Pacific Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 Rest of Asia Pacific Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
o Latin America
 Brazil
 Brazil Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 Brazil Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
 Mexico
 Mexico Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 Mexico. Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
 Rest of Latin America
 Rest of Latin America Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 Rest of Latin America Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
o Middle East
 GCC
 GCC Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 GCC Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
 Israel
 Israel Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 Israel Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
 Rest of Middle East
 Rest of Middle East Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 Rest of Middle East Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
o Africa
 North Africa
 North Africa Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 North Africa Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
 Central Africa
 Central Africa Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 Central Africa Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
 South Africa
 South Africa Companion Diagnostics Market, By Application:
 Breast Cancer
 Lung Cancer
 Colorectal Cancer
 Gastric Cancer
 Melanoma
 Others
 South Africa Companion Diagnostics Market, By Technology:
 Immunohistochemistry
 Real Time PCR
 Gene Sequencing
 FISH
 Others
• Company Profiles
o Abbott Laboratories, Inc. *
 Company Overview
 Product Portfolio
 Financial Performance
 Key Strategies
 Recent Developments
 Future Plans
o Agilent Technologies, Inc.
o Danaher Corporation
o GE Healthcare
o Qiagen N.V.
o Roche Diagnostics
o Myriad Genetics, Inc.
o bioMérieux SA
o Siemens Healthcare
o Illumina, Inc.
"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents
1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet By Application
? Market Snippet By Technology
? Market Snippet By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Supply Side Drivers
? Demand Side Drivers
? Economic Drivers
? Restraints
? Market Opportunities
? Regulatory Scenario
? Industry Trend
? Epidemiology/Prevalence/Incidence
? Merger and Acquisitions
? New Product Approvals/Launch
? Promotion and Marketing Initiatives
o Cost Tier Down Analysis
4. Global Biopharmaceuticals and Biomedicine Market, By Application, 2014 - 2024 (US$ Million)
o Introduction
? Market Share Analysis, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, 2014 - 2024
? Segment Trends
o Breast Cancer
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Lung Cancer
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Colorectal Cancer
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Gastric Cancer
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Melanoma
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Others
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
5. Global Biopharmaceuticals and Biomedicine Market, By Technology, 2014 - 2024 (US$ Million)
o Introduction
? Market Share Analysis, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, 2014 - 2024
? Segment Trends
o Real-Time PCR
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Gene Sequencing
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o FISH
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Others
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
6. Global Biopharmaceuticals and Biomedicine Market, By Regions, 2014 - 2024 (US$ Million)
o Introduction
? Market Share Analysis, By Region, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, For Regions, 2014 - 2024
o North America
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? U.S.
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Canada
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
o Europe
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? U.K.
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Germany
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Italy
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? France
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Russia
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Rest of Europe
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
o Asia Pacific
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? China
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? India
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Japan
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? ASEAN
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Australia
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? South Korea
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Rest of Asia Pacific
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
o Latin America
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? Brazil
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Mexico
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Rest of Latin America
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
o Middle East
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? GCC Countries
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Israel
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Rest of Middle East
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
o Africa
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? Northern Africa
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? Central Africa
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
? South Africa
? Country Trends
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Technology, 2014 - 2024 (US$ Million)
7. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profiles
? Abbott Laboratories, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Agilent Technologies, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Danaher Corporation
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? GE Healthcare
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Qiagen N.V.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Roche Diagnostics
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? bioMérieux SA
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Myriad Genetics, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Siemens Healthcare
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Illumina, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
o Analyst Views
8. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 90 market data tables and 40 figures on "Biopharmaceuticals and Biomedicine Market - Global forecast to 2024".
 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us